What is the recommended surveillance protocol for cerebral aneurysms in family members with a history of cerebral (Cerebral) aneurysms?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 9, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Family members with a history of cerebral aneurysms should undergo radiological screening for aneurysms every 5 to 7 years.

Recommended Surveillance Protocol

The recommended surveillance protocol is based on the presence of ≥2 first-degree relatives with known cerebral aneurysms, which increases the risk of harboring a cerebral aneurysm to 12% 1.

  • Screening interval: Every 5 to 7 years for individuals 20 to 80 years of age with a family history of ≥2 first-degree relatives with known cerebral aneurysms 1.
  • Screening modality: Noninvasive imaging such as MRA or CTA is recommended for screening 1.
  • Risk factors: Hypertension, tobacco use, and family history are important risk factors for cerebral aneurysms, and screening may be beneficial in individuals with these risk factors 1.
  • Cost-effectiveness: Radiological screening for aneurysms is cost-effective when performed every 5 to 7 years for individuals with a family history of ≥2 first-degree relatives with known cerebral aneurysms 1. It is essential to note that the American Heart Association guidelines recommend offering screening to patients with 2 family members with intracranial aneurysms or SAH 1, and noninvasive screening for unruptured intracranial aneurysms in patients with no more than 1 relative with SAH or intracranial aneurysms is not recommended 1.

From the Research

Surveillance Protocol for Cerebral Aneurysms in Family Members

The recommended surveillance protocol for cerebral aneurysms in family members with a history of cerebral aneurysms is as follows:

  • Screening is currently recommended in families with ≥2 affected first-degree relatives 2, 3
  • Individuals with ≥1 affected first-degree relative may also benefit from screening, as they have a higher prevalence of intracranial aneurysms (average 4.8%) and an increased risk of subarachnoid hemorrhage 2
  • Repeated screening should be considered in relatives who have been treated for familial intracranial aneurysms 3
  • The yield of screening is high in first-degree members of families with familial subarachnoid hemorrhage, making it a recommended practice 3

Factors Associated with Increased Risk of Intracranial Aneurysms

Several factors are associated with an increased risk of intracranial aneurysms, including:

  • A history of treatment for ruptured or unruptured intracranial aneurysms (relative risk 5.5) 3
  • Having three or more affected relatives (relative risk 3.3) 3
  • Initial aneurysm size, with larger aneurysms having a higher risk of growth and rupture 4, 5
  • Aneurysm growth, which is associated with an increased risk of subarachnoid hemorrhage 4, 5

Imaging Follow-up for Untreated Unruptured Intracranial Aneurysms

Imaging follow-up is recommended for patients with untreated unruptured intracranial aneurysms, including those with aneurysms smaller than the current treatment threshold of 7 mm 4, 5

  • The risk of aneurysm rupture per patient-year is 5% with growth, and 0.2% without growth 4
  • Aneurysm size is the only predictor of future growth, with larger aneurysms having a higher risk of growth and rupture 5
  • More frequent (semiannual) surveillance imaging may be warranted for newly diagnosed aneurysms and aneurysms ≥ 5 mm 5

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.